NANO MRNA Statistics
Total Valuation
NANO MRNA has a market cap or net worth of JPY 10.02 billion. The enterprise value is 7.06 billion.
Market Cap | 10.02B |
Enterprise Value | 7.06B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NANO MRNA has 70.60 million shares outstanding. The number of shares has increased by 0.32% in one year.
Current Share Class | 70.60M |
Shares Outstanding | 70.60M |
Shares Change (YoY) | +0.32% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 3.17% |
Owned by Institutions (%) | 2.95% |
Float | 65.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 92.82 |
PB Ratio | 3.66 |
P/TBV Ratio | 3.66 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -8.45 |
EV / Sales | 65.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.01, with a Debt / Equity ratio of 0.20.
Current Ratio | 3.01 |
Quick Ratio | 2.91 |
Debt / Equity | 0.20 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -27.11% and return on invested capital (ROIC) is -12.09%.
Return on Equity (ROE) | -27.11% |
Return on Assets (ROA) | -10.41% |
Return on Invested Capital (ROIC) | -12.09% |
Return on Capital Employed (ROCE) | -27.03% |
Revenue Per Employee | 5.40M |
Profits Per Employee | -41.75M |
Employee Count | 20 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NANO MRNA has paid 2.00 million in taxes.
Income Tax | 2.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.06% in the last 52 weeks. The beta is 0.14, so NANO MRNA's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | -24.06% |
50-Day Moving Average | 134.30 |
200-Day Moving Average | 149.11 |
Relative Strength Index (RSI) | 55.59 |
Average Volume (20 Days) | 1,044,660 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NANO MRNA had revenue of JPY 108.00 million and -835.00 million in losses. Loss per share was -11.84.
Revenue | 108.00M |
Gross Profit | 78.00M |
Operating Income | -755.00M |
Pretax Income | -833.00M |
Net Income | -835.00M |
EBITDA | -754.00M |
EBIT | -755.00M |
Loss Per Share | -11.84 |
Balance Sheet
The company has 3.51 billion in cash and 540.00 million in debt, giving a net cash position of 2.97 billion or 42.00 per share.
Cash & Cash Equivalents | 3.51B |
Total Debt | 540.00M |
Net Cash | 2.97B |
Net Cash Per Share | 42.00 |
Equity (Book Value) | 2.74B |
Book Value Per Share | 38.80 |
Working Capital | 2.42B |
Cash Flow
Operating Cash Flow | -401.00M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 72.22% |
Operating Margin | -699.07% |
Pretax Margin | -771.30% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NANO MRNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.32% |
Shareholder Yield | n/a |
Earnings Yield | -8.33% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 27, 2014. It was a forward split with a ratio of 100.
Last Split Date | Mar 27, 2014 |
Split Type | Forward |
Split Ratio | 100 |
Scores
NANO MRNA has an Altman Z-Score of 4.81 and a Piotroski F-Score of 1.
Altman Z-Score | 4.81 |
Piotroski F-Score | 1 |